Episode 64

full
Published on:

24th Mar 2026

Can We Really Extend Healthspan? Only If You're Rich

Our latest discussion explores the universal desire for a healthy, long life, emphasizing that aging is a primary driver of disease. We consider various approaches to healthy ageing and the pursuit of a longer healthspan. While true solutions for how to live longer currently favor the wealthy, understanding aging biology and metabolic health are crucial for disease prevention. This episode prompts us to rethink access to longevity solutions for everyone.

In this conversation, Kaushik Trivedi and Dylan Livingston explore the implications of aging as a treatable condition rather than an inevitable decline. They discuss the role of policy in shaping longevity research, the need for societal acceptance of aging interventions, and the potential economic benefits of extending healthy lifespans. The conversation also touches on the risks associated with longevity breakthroughs and the importance of making these advancements accessible to all. Ultimately, they emphasize the need for a shift in healthcare from reactive to proactive measures, highlighting the societal changes that could arise from longer, healthier lives.


Chapters

00:00 The Uncomfortable Truth About Aging

01:26 The Disruption of Aging Policy

03:11 Dylan's Journey into Longevity Advocacy

08:44 Bridging Science and Policy

10:24 The Need for Diverse Voices in Longevity

12:12 Inspiration from Pioneers in the Field

13:04 The Unconventional Path to Advocacy

15:16 Curiosity Over Skepticism in Policy Discussions

19:18 Bipartisan Support for Longevity Initiatives

24:34 Aging 1.0 vs. Aging 2.0

27:07 The Economic Impact of Healthy Aging

30:11 Making Longevity Accessible to All

32:41 The Role of Government in Longevity Drug Accessibility

34:08 Awareness and Misconceptions in Longevity

36:51 Realism vs. Hype in Longevity Innovations

39:25 Mainstreaming Longevity Medicine

43:42 Government's Role in Longevity Interventions

47:35 Societal Changes with Extended Lifespan

53:09 The Future of Work and Leisure in an AI-Driven World

54:07 Potential Risks of Extended Lifespan

56:21 Hope and Challenges in Longevity Advocacy


If you'd like to sponsor the show and elevate your brand with our audience, reach out to show host Kaushik Trivedi on LinkedIn and his team will reach out to fix up a chat to explore.


Connect with Kaushik Trivedi:

Instagram: https://www.instagram.com/drugdiaries_/

Next Episode All Episodes Previous Episode

Listen for free

Show artwork for Drug Diaries

About the Podcast

Drug Diaries
Welcome to "Drug Diaries," the podcast exploring pharmaceuticals, life sciences, and biotechnology. Host Kaushik Trivedi, with over two decades of industry experience, shares his expertise. Kaushik has worked with IQVIA, Cognizant, Wipro, and more, and holds degrees in pharmaceutical chemistry, marketing, and advertising. Kaushik's expertise spans: - Data-Driven GTM & Customer Engagement - CRM, Marketing Cloud, SFE, & Commercial Analytics - AI/ML/NLP in Life Sciences - Population Health Management - IoT & Connected Devices - Content Production & MLR Approval - R&D, Clinical, Pharmacovigilance, Medical, & Regulatory - Business Transformation "Drug Diaries" covers research, drug discovery, AI in health, GTM strategies, customer engagement, analytics, patient safety, product engineering, and more. Join Kaushik for insights and discussions on the ever-evolving pharma and biotech landscape. Each episode is a deep dive into the industry's heart. Welcome to "Drug Diaries."

About your host

Profile picture for Kaushik Trivedi

Kaushik Trivedi